JP2015520186A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520186A5 JP2015520186A5 JP2015515992A JP2015515992A JP2015520186A5 JP 2015520186 A5 JP2015520186 A5 JP 2015520186A5 JP 2015515992 A JP2015515992 A JP 2015515992A JP 2015515992 A JP2015515992 A JP 2015515992A JP 2015520186 A5 JP2015520186 A5 JP 2015520186A5
- Authority
- JP
- Japan
- Prior art keywords
- oxo
- dihydro
- naphthyridin
- ethyl
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1cc(N(*)C(C(c(c(*)c2)cc(NC(N*)=O)c2F)=C2)=O)c2cn1 Chemical compound Cc1cc(N(*)C(C(c(c(*)c2)cc(NC(N*)=O)c2F)=C2)=O)c2cn1 0.000 description 2
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2012/041378 WO2013184119A1 (en) | 2012-06-07 | 2012-06-07 | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015520186A JP2015520186A (ja) | 2015-07-16 |
| JP2015520186A5 true JP2015520186A5 (https=) | 2015-08-27 |
| JP5883195B2 JP5883195B2 (ja) | 2016-03-09 |
Family
ID=49712374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015515992A Active JP5883195B2 (ja) | 2012-06-07 | 2012-06-07 | 増殖性疾患の治療にキナーゼ阻害剤として有用なジヒドロナフチリジン及び関連化合物 |
Country Status (28)
| Country | Link |
|---|---|
| EP (3) | EP3722296A3 (https=) |
| JP (1) | JP5883195B2 (https=) |
| KR (1) | KR101652229B1 (https=) |
| CN (3) | CN110433162A (https=) |
| AU (1) | AU2012327210B2 (https=) |
| BR (1) | BR112014030577B1 (https=) |
| CA (1) | CA2875970C (https=) |
| CY (1) | CY1123377T1 (https=) |
| DK (2) | DK3366293T3 (https=) |
| ES (2) | ES2663605T3 (https=) |
| FR (1) | FR22C1013I2 (https=) |
| HR (1) | HRP20200864T1 (https=) |
| HU (2) | HUE049958T2 (https=) |
| IL (1) | IL236110A (https=) |
| LT (2) | LT3366293T (https=) |
| LU (1) | LUC00253I2 (https=) |
| MX (2) | MX372814B (https=) |
| NL (1) | NL301169I2 (https=) |
| NO (1) | NO2022010I1 (https=) |
| PH (2) | PH12018502294B1 (https=) |
| PL (1) | PL3366293T3 (https=) |
| PT (2) | PT3366293T (https=) |
| RS (1) | RS60406B1 (https=) |
| RU (1) | RU2664055C2 (https=) |
| SG (1) | SG11201408133TA (https=) |
| SI (1) | SI3366293T1 (https=) |
| SM (1) | SMT202000302T1 (https=) |
| WO (1) | WO2013184119A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| MY181020A (en) | 2013-03-15 | 2020-12-16 | Sanofi Sa | Heteroaryl compounds and uses thereof |
| TWI647220B (zh) | 2013-03-15 | 2019-01-11 | 美商西建卡爾有限責任公司 | 雜芳基化合物及其用途 |
| MA38393B1 (fr) | 2014-03-13 | 2018-11-30 | Sanofi Sa | Composés hétéroaryle et utilisations associées |
| SG11201805869XA (en) * | 2016-01-11 | 2018-08-30 | Merck Patent Gmbh | Quinolin-2-one derivatives |
| CA3065365C (en) * | 2017-05-30 | 2025-09-16 | Deciphera Pharmaceuticals, Llc | USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDINE-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ITS ANALOGUES FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN THE PLATELET-DERIVED GROWTH FACTOR ALPHA RECEPTOR |
| WO2019056990A1 (zh) * | 2017-09-20 | 2019-03-28 | 浙江海正药业股份有限公司 | 1,2-二氢-1,6-萘啶类衍生物、其制备方法及其在医药上的用途 |
| IL276398B2 (en) | 2018-01-31 | 2026-03-01 | Deciphera Pharmaceuticals Llc | Combination therapy for mastocytosis |
| KR102708177B1 (ko) * | 2018-01-31 | 2024-09-23 | 데시페라 파마슈티칼스, 엘엘씨. | 위장관 기질 종양의 치료를 위한 병용 요법 |
| EP3938363A1 (en) * | 2019-03-11 | 2022-01-19 | Teva Pharmaceuticals International GmbH | Solid state forms of ripretinib |
| US10927111B2 (en) | 2019-05-03 | 2021-02-23 | Kinnate Biopharma Inc. | Inhibitors of RAF kinases |
| PT4013412T (pt) | 2019-08-12 | 2026-03-18 | Deciphera Pharmaceuticals Llc | Ripretinib para o tratamento de tumores estromais gastrointestinais |
| LT4013412T (lt) | 2019-08-12 | 2026-03-25 | Deciphera Pharmaceuticals, Llc | Ripretinibas, skirtas virškinamojo trakto stromos navikų gydymui |
| US20240075041A1 (en) * | 2019-10-04 | 2024-03-07 | Blueprint Medicines Corporation | Treatment of eosinophilic disorders with avapritinib |
| BR112022007612A2 (pt) | 2019-10-24 | 2022-09-20 | Kinnate Biopharma Inc | Inibidores de raf quinases |
| CN115243681B (zh) | 2019-12-30 | 2024-08-16 | 德西费拉制药有限责任公司 | 1-(4-溴-5-(1-乙基-7-(甲氨基)-2-侧氧基-1,2-二氢-1,6-萘啶-3-基)-2-氟苯基)-3-苯基脲的组合物 |
| HRP20231699T1 (hr) * | 2019-12-30 | 2024-05-10 | Deciphera Pharmaceuticals, Llc | Formulacije inhibitora amorfne kinaze i postupci njihove primjene |
| KR102535840B1 (ko) | 2020-07-31 | 2023-05-23 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물의 위장관기질종양 예방, 개선 또는 치료 용도 |
| US11407737B2 (en) | 2020-09-18 | 2022-08-09 | Kinnate Biopharma Inc. | Inhibitors of RAF kinases |
| WO2022081469A1 (en) | 2020-10-12 | 2022-04-21 | Kinnate Biopharma Inc. | Inhibitors of raf kinases |
| CN112625038A (zh) * | 2020-12-31 | 2021-04-09 | 武汉九州钰民医药科技有限公司 | 制备瑞普替尼的方法 |
| WO2022162690A1 (en) * | 2021-01-28 | 2022-08-04 | Dr. Reddy's Laboratories Limited | Process for the preparation of ripretinib and solid state forms thereof |
| CN117561057A (zh) | 2021-04-23 | 2024-02-13 | 金耐特生物制药公司 | 用raf抑制剂治疗癌症 |
| EP4476218A1 (en) * | 2021-12-24 | 2024-12-18 | Assia Chemical Industries Ltd. | Improved processes for the preparation of ripretinib |
| CN114213411B (zh) * | 2022-01-24 | 2023-06-30 | 成都伊诺达博医药科技有限公司 | 一种瑞普替尼的合成方法 |
| US11814384B2 (en) | 2022-02-03 | 2023-11-14 | Kinnate Biopharma Inc. | Inhibtors of Raf kinases |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004279427B2 (en) * | 2003-10-08 | 2008-07-03 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| DE102006030524A1 (de) * | 2006-07-01 | 2008-01-03 | Koch Transporttechnik Gmbh | Verfahren und Vorrichtung zur Beseitigung von lockerem Material auf wellenförmigen Oberflächen gestampfter Kohle für die Verkokung |
| US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| CN101516379A (zh) * | 2006-09-14 | 2009-08-26 | 迪赛孚尔制药有限公司 | 可用于治疗增殖性疾病的激酶抑制剂 |
| EA200900573A1 (ru) * | 2006-10-20 | 2009-10-30 | АйАрЭм ЭлЭлСи | Композиции и способы для модуляции рецепторов c-kit и pdgfr |
| CA2714700C (en) * | 2008-02-22 | 2013-07-30 | Irm Llc | Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
-
2012
- 2012-06-07 DK DK17208408.9T patent/DK3366293T3/da active
- 2012-06-07 DK DK12878321.4T patent/DK2858646T3/en active
- 2012-06-07 AU AU2012327210A patent/AU2012327210B2/en active Active
- 2012-06-07 PL PL17208408T patent/PL3366293T3/pl unknown
- 2012-06-07 JP JP2015515992A patent/JP5883195B2/ja active Active
- 2012-06-07 SG SG11201408133TA patent/SG11201408133TA/en unknown
- 2012-06-07 CN CN201910368783.1A patent/CN110433162A/zh active Pending
- 2012-06-07 CA CA2875970A patent/CA2875970C/en active Active
- 2012-06-07 WO PCT/US2012/041378 patent/WO2013184119A1/en not_active Ceased
- 2012-06-07 EP EP20161887.3A patent/EP3722296A3/en active Pending
- 2012-06-07 EP EP12878321.4A patent/EP2858646B1/en active Active
- 2012-06-07 CN CN201910368784.6A patent/CN110403938A/zh active Pending
- 2012-06-07 HU HUE17208408A patent/HUE049958T2/hu unknown
- 2012-06-07 ES ES12878321.4T patent/ES2663605T3/es active Active
- 2012-06-07 EP EP17208408.9A patent/EP3366293B1/en active Active
- 2012-06-07 MX MX2014015024A patent/MX372814B/es active IP Right Grant
- 2012-06-07 RS RS20200633A patent/RS60406B1/sr unknown
- 2012-06-07 BR BR112014030577-3A patent/BR112014030577B1/pt active IP Right Grant
- 2012-06-07 CN CN201280075113.7A patent/CN104902895B/zh active Active
- 2012-06-07 PH PH1/2018/502294A patent/PH12018502294B1/en unknown
- 2012-06-07 SI SI201231785T patent/SI3366293T1/sl unknown
- 2012-06-07 SM SM20200302T patent/SMT202000302T1/it unknown
- 2012-06-07 ES ES17208408T patent/ES2797252T3/es active Active
- 2012-06-07 MX MX2020005712A patent/MX392372B/es unknown
- 2012-06-07 RU RU2014153920A patent/RU2664055C2/ru active
- 2012-06-07 KR KR1020157000365A patent/KR101652229B1/ko active Active
- 2012-06-07 LT LTEP17208408.9T patent/LT3366293T/lt unknown
- 2012-06-07 PT PT172084089T patent/PT3366293T/pt unknown
- 2012-06-07 PT PT128783214T patent/PT2858646T/pt unknown
-
2014
- 2014-12-07 IL IL236110A patent/IL236110A/en active IP Right Grant
- 2014-12-09 PH PH12014502757A patent/PH12014502757B1/en unknown
-
2020
- 2020-05-29 HR HRP20200864TT patent/HRP20200864T1/hr unknown
- 2020-06-10 CY CY20201100530T patent/CY1123377T1/el unknown
-
2022
- 2022-04-05 LU LU00253C patent/LUC00253I2/fr unknown
- 2022-04-07 NO NO2022010C patent/NO2022010I1/no unknown
- 2022-04-07 FR FR22C1013C patent/FR22C1013I2/fr active Active
- 2022-04-12 NL NL301169C patent/NL301169I2/nl unknown
- 2022-05-03 LT LTPA2022008C patent/LTC3366293I2/lt unknown
- 2022-05-09 HU HUS2200017C patent/HUS2200017I1/hu unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015520186A5 (https=) | ||
| RU2014153920A (ru) | Дигидронафтиридины и родственные соединения, подходящие в качестве ингибиторов киназ для лечения пролиферативных заболеваний | |
| USRE48731E1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| TWI579284B (zh) | 咪唑并吡咯啶酮化合物 | |
| JP7567041B2 (ja) | ヒストン脱アセチル化酵素６阻害剤としての新規な構造の化合物およびこれを含む薬剤学的組成物 | |
| WO2004010949A3 (en) | Compounds active in spinigosine 1-phosphate signaling | |
| JP2017537882A5 (https=) | ||
| CA2566544A1 (en) | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases | |
| RU2010150786A (ru) | Пирролопиридины как ингибиторы киназы | |
| NO20073283L (no) | Nye pyridotienopyrimidinderivater | |
| JP2017503840A5 (https=) | ||
| CA2447765A1 (en) | 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors | |
| JP2019530708A5 (https=) | ||
| CA2617817A1 (en) | Thiazole derivatives for treating or preventing sleep disorders | |
| AU2012233246B2 (en) | Novel furanone derivative | |
| EP2588470A1 (en) | Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity | |
| RU2018107578A (ru) | Дигидронафтиридины и родственные соединения, подходящие в качестве ингибиторов киназ для лечения пролиферативных заболеваний | |
| RU2804468C2 (ru) | Дигидронафтиридины и родственные соединения, подходящие в качестве ингибиторов киназ для лечения пролиферативных заболеваний | |
| RU2014136226A (ru) | Производные имидазолилкетона в качестве ингибиторов альдостеронсинтазы | |
| JP2025530864A (ja) | Ｅｇｆｒ変異体に対する生物学的活性を有するキナーゼ阻害剤としての新規ピリミジン化合物 | |
| HK40039059A (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| HK1209345B (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| MX2008000781A (es) | Derivados de triazol substituidos y su uso como antagonistas del receptor neuroquinina 3. |